In an experimental study examining cardiomyocytes exposed to hyperglycemia, DATS administration reduced OS primarily by increasing the expression of antioxidants (HO-1, SOD-1, and SOD-2) via upregulation of Nrf2 expression and its translocation to the nucleus. This evidence concerns the gene SOD1 and Hyperglycemia.